NCT06870630

Brief Summary

\- Consecutive eligible patients will be randomized in a 1:1 ratio to esophagogastric complex only myotomy or standard myotomy groups. Randomization is done according to the computer-generated algorithm. A clinical research coordinator will prepare the sealed randomization envelops and will hand over to the operating endoscopists before the beginning of the procedure. Written informed consent will be obtained from all participants. In this study, the participants and the care-provider assessing the clinical response to the POEM procedure at 3months will be blinded to the allocation.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
158

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2023

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 29, 2023

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

March 6, 2025

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 11, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 14, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2025

Completed
Last Updated

June 10, 2025

Status Verified

March 1, 2025

Enrollment Period

1.5 years

First QC Date

March 6, 2025

Last Update Submit

June 9, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Incidence of true reflux based on 24-hour pH impedence

    Reflux parameters in percent are noted in impedence report like acidic and non acidic refluxes

    3 months

  • Integrated Relaxation Pressure (IRP) at High resolution manometry test

    IRP in mm Hg measures pressure in the esophagus

    3 months

Study Arms (2)

Per oral endoscopy myotomy for standard myotomy

ACTIVE COMPARATOR

Standard myotomy is muscle fibers cutting in esophagus more than 7 cms

Device: Per oral endoscopy myotomy

Per oral endoscopy myotomy for esophago gastric junction myotomy

SHAM COMPARATOR

Myotomy is muscle fibers cutting in esophagus less than 3 cms.

Device: Per oral endoscopy myotomy

Interventions

Poem procedure is meant for cutting of circular and longitudinal muscle fibers in esophagus to reduce the symptoms of dysphagia, regurgitation and chestpain, weight loss.

Per oral endoscopy myotomy for esophago gastric junction myotomyPer oral endoscopy myotomy for standard myotomy

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult \>18 years
  • Diagnosis of Type 2 Achalasia cardia based on High resolution manometry.

You may not qualify if:

  • Patients with Type 1 \& 3 ACHALASIA CARDIA
  • Patients with previous endoscopic or surgical treatment for achalasia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Asian Institute of Gastroenterology /Aig Hospitals

Hyderabad, Telangana, 500082, India

RECRUITING

MeSH Terms

Conditions

Esophageal Diseases

Condition Hierarchy (Ancestors)

Gastrointestinal DiseasesDigestive System Diseases

Study Officials

  • Mohan Dr Ramchandani, MBBS MD

    AIG Hospitals

    STUDY DIRECTOR
  • Zaheer Dr Nabi, MBBS MD

    AIG Hospitals

    PRINCIPAL INVESTIGATOR
  • Pradev Dr Inovolu, MBBS MD

    AIG Hospitals

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Rajesh Dr Goud, M.Pharm, MBA

CONTACT

Sreejith Dr OT, MBBS MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director

Study Record Dates

First Submitted

March 6, 2025

First Posted

March 11, 2025

Study Start

November 29, 2023

Primary Completion

June 14, 2025

Study Completion

July 30, 2025

Last Updated

June 10, 2025

Record last verified: 2025-03

Locations